LONDON UK, July 24, 2019 - Rapid Nutrition PLC (“Company”), a natural healthcare company focused on the research, development and production of a range of life science products, announced today it has expanded its distribution partnering with ASX listed pharmaceutical company Sigma Healthcare to launch health and wellness giant GNC further across the Australian pharmacy network.

Under the terms of the partnership, Rapid Nutrition’s SystemLS and GNC health products will now be available through Sigma Healthcare’s retail brand Discount Drug Stores (DDS), which recently was awarded the Australian Chemist / Pharmacy of the Year as a result of receiving the highest customer satisfaction ratings in 2018.

Sigma Healthcare is a leading Australian wholesale and distribution business to community and hospital pharmacies, generating $4 billion in revenues across more than 1,200 stores in its growing network offering its retail brands Amcal+, Chemist King, Discount Drug Stores, Guardian and Pharma Save.

“We are pleased to unite two of the most prominent life science market leaders as we continue our mission to increase the accessibility of health and wellness products throughout Australia,” said Rapid Nutrition CEO Simon St. Ledger. “Innovation continues to drive our company, resulting in key partnerships, financial growth and a steadily widening footprint in Australia and across the globe.”

Investor Relations Contact:

About Rapid Nutrition
Rapid Nutrition is a natural healthcare company focused on the research, development and production of a range of life science products. The company was established based on its successful and proven weight loss supplement range which is exported worldwide and now offers consumers a growing range of health and well-being solutions to meet existing and emerging societal health concerns, as well as a providing number of wider services to the life sciences industry. For more information, please visit

Forward-Looking Statements This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLC’s actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.

Disclosure Requirement: This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning of article 652a or article 1156 of the Swiss Code of Obligations or a listing prospectus within the meaning of the listing rules of the SIX Swiss Exchange. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reportingExchange Act Rule 12g3-2(b).

Subscribe for Updates